- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Vorinostat, capecitabine, and cisplatin
Total 5314 results
-
Memorial Sloan Kettering Cancer CenterCompletedGastric Cancer | Esophageal CancerUnited States
-
Eli Lilly and CompanyCompleted
-
Johns Hopkins All Children's HospitalTerminatedCentral Nervous System TumorsUnited States
-
Merck Sharp & Dohme LLCCompletedMyelodysplastic Syndromes | Leukemia, Myelocytic, Acute Myelodysplastic Syndromes
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Eye & ENT Hospital of Fudan UniversityShandong Provincial Hospital; Harbin Medical University Third Affiliated HospitalRecruitingHypopharyngeal CarcinomaChina
-
National Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; M.D. Anderson Cancer Center; Merck Sharp & Dohme LLC; Dana-Farber Cancer Institute and other collaboratorsCompletedSolid Tumors | Relapsed/Refractory SarcomasUnited States, Canada
-
Sun Yat-sen UniversityCompletedNasopharyngeal NeoplasmsChina
-
Hoffmann-La RocheCompletedGastric CancerFrance, Belgium, Korea, Republic of, Spain, Czechia, Germany, Italy, Netherlands
-
National Cancer Institute (NCI)CompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Merck Sharp & Dohme LLCCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Localized Transitional Cell Cancer of the...United States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma | Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma | Adult Favorable Prognosis... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
Raghu Nandan, M.D., IncUnknown
-
Spanish Lung Cancer GroupMerck Sharp & Dohme LLCTerminatedNon-small Cell Lung CancerSpain
-
UNICANCERMerck Sharp & Dohme LLC; Fondation ARC; ERA-NETActive, not recruitingVulvar Cancer | Cervix Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Penile Cancer | Squamous Cell Lung CancerFrance
-
Ruijin HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
PfizerCompletedStomach NeoplasmsKorea, Republic of
-
Sun Yat-sen UniversityChengdu Biostar PharmaceuticalsNot yet recruitingBreast Neoplasms | Locally Advanced or Metastatic Breast CancerChina
-
Jeroen Bosch ZiekenhuisEindhoven Cancer RegistryCompleted
-
AmgenTerminatedGastric CancerKorea, Republic of, Japan
-
University of WashingtonNational Cancer Institute (NCI)TerminatedCutaneous T-cell Lymphoma Stage I | Cutaneous T-cell Lymphoma Stage II | Cutaneous T-cell Lymphoma Stage III | Cutaneous T-cell Lymphoma Stage IVUnited States
-
Masonic Cancer Center, University of MinnesotaWithdrawnCervical CancerUnited States
-
BeiGeneActive, not recruitingGastric, or Gastroesophageal Junction AdenocarcinomaUnited States, China, Spain, Korea, Republic of, Poland, Russian Federation, Taiwan, France, Turkey, Japan, Italy, United Kingdom, Puerto Rico
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Stage...United States, South Africa
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Hoffmann-La RocheCompletedBreast Cancer, Colorectal CancerNew Zealand, Australia, United Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
Professor David CunninghamGlaxoSmithKline; Roche Pharma AG; Cancer Research UKUnknownOesophagogastric CancerUnited Kingdom
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Asan Medical CenterRoche Pharma AGCompletedAdvanced Gastric CancerKorea, Republic of
-
Zhiyong YuUnknownBreast Cancer | Chemotherapy Effect | Disease-free Survival
-
Hoffmann-La RocheCompletedGastric CancerHong Kong, Colombia, Russian Federation, Peru, Korea, Republic of, China, Mexico, Brazil, Argentina, Guatemala, Uruguay, Malaysia, Belize, Panama
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Nanfang Hospital of Southern Medical UniversityUnknown
-
Asan Medical CenterCompletedStage IV Gastric Cancer With MetastasisKorea, Republic of
-
Peking University Cancer Hospital & InstituteUnknown
-
Fudan UniversityCompletedMetastatic Breast CancerChina
-
City of Hope Medical CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedLymphomaUnited States
-
West China Second University HospitalRecruitingNeoadjuvant Chemotherapy | Epithelial Carcinoma, OvarianChina
-
Merck Sharp & Dohme LLCCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer
-
Privo TechnologiesNational Cancer Institute (NCI)CompletedOral Squamous Cell CarcinomaUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEsophageal Squamous Cell CarcinomaChina